Skip to content
Screener

Embecta Corp. EMBC Q2 2025 earnings

Reported May 9, 2025 · Before market open

Revenue$259.0MMiss by $19.8M
EPS$0.70Beat by $0.04
Revenue estimate$278.8M
EPS estimate$0.66

Next report

Nov 24, 2026 (in 2 months)
Revenue estimate$269.7M
EPS estimate$0.31

Financials

Q2 2025

Income statement

See full
Revenue$259.0M-9.8%
Gross profit$164.1M-11.5%
Operating income$62.9M+60.5%
Net income$23.5M-18.7%
EPS (diluted)$0.40-20.0%

Balance sheet

See full
Cash & equivalents$212.3M-30.7%
Total debt$1.6B-5.3%
Total equity-$736.2M+4.3%
Total assets$1.1B-6.6%

Cash flow

See full
Operating cash flow$31.8M+30.9%
CapEx$100.0K-97.1%
Free cash flow$31.7M+51.7%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$741.21M-2.8%
Enterprise value$2.1B-0.7%
P/E14×+3.2×
P/S0.7×0.0×

Profitability

See full
Gross margin63.5%-2.1pp
Operating margin16.1%+1.8pp
Net margin4.9%-1.3pp
FCF margin3.7%—

Returns & leverage

See full
Current ratio2.5×+0.2×

Segments

By product

See full
Pen Needles$188.3M-13.7%
Safety$34.2M+2.7%
Syringes$28.8M-4.0%
Contract Manufacturing$4.4M+69.2%

By geography

See full
United States$135.2M—

FAQ

When did Embecta Corp. report Q2 2025 earnings?
Embecta Corp. (EMBC) reported Q2 2025 earnings on May 9, 2025 before market open.
What were Embecta Corp.'s Q2 2025 revenue and EPS?
Embecta Corp. reported revenue of $259.0M and eps of $0.70 for Q2 2025.
Did Embecta Corp. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $278.8M by $19.8M. EPS beat the consensus estimate of $0.66 by $0.04.
How did Embecta Corp.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 9.8% from $287.2M a year earlier and eps grew 4.5% from $0.67.
Where can I find Embecta Corp.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001872789-25-000009) and the 10-Q periodic report (0001872789-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.